SCHEMBL7835675

SCHEMBL7835675

CNc1cc(NS(=O)(=O)c2cccc(Cl)c2)nc(NC)n1

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HTR6 P50406 3/20 0.61
▸ MAPT P10636 3/20 0.61
▸ ALDH1A1 P00352 1/20 0.61
▸ CYP3A4 P08684 1/20 0.61
▸ CYP2C9 P11712 1/20 0.61
▸ CYP2C19 P33261 1/20 0.61
▸ RAB9A P51151 1/20 0.61
▸ KDM4E B2RXH2 1/20 0.60
▸ APEX1 P27695 1/20 0.60
▸ BLM P54132 1/20 0.60
▸ NPSR1 Q6W5P4 1/20 0.60
▸ PGR P06401 7/20 0.51
▸ PKM P14618 1/20 0.49
▸ EDNRB P24530 1/20 0.48
▸ EDNRA P25101 1/20 0.48
▸ SLC40A1 Q9NP59 1/20 0.48
▸ LMNA P02545 1/20 0.48
▸ TDP1 Q9NUW8 1/20 0.48
▸ FBP1 P09467 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7826180 0.91 PGR (0.50) HTR6MAPTALDH1A1CYP3A4CYP2C9
SCHEMBL7824099 0.85 HTR6 (0.74) HTR6MAPTALDH1A1CYP3A4CYP2C9
SCHEMBL7837566 0.84 HTR6 (0.74) HTR6MAPTALDH1A1CYP3A4CYP2C9
SCHEMBL7823443 0.83 PGR (0.61) HTR6MAPTPGRPKMEDNRB
SCHEMBL7824814 0.82 HTR6 (0.59) HTR6MAPTALDH1A1CYP3A4CYP2C9
SCHEMBL7825681 0.78 HTR6 (0.57) HTR6MAPTALDH1A1CYP3A4CYP2C9
SCHEMBL7836254 0.77 HTR6 (0.76) HTR6MAPTALDH1A1CYP3A4CYP2C9
SCHEMBL678897 0.76 HTR6 (1.00) HTR6MAPTALDH1A1CYP3A4CYP2C9
SCHEMBL7824884 0.76 HTR6 (0.74) HTR6MAPTALDH1A1CYP3A4CYP2C9
SCHEMBL7833307 0.76 MEN1 (0.55) HTR6MAPTALDH1A1CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0815861-B1 Sulphonamides and their use HOFFMANN LA ROCHE (CH) 2001-09-19 — — EP claimed
EP-0815861-A1 Sulphonamides and their use F. HOFFMANN-LA ROCHE AG (CH) 1998-01-07 — — EP claimed
EP-0815861-B1 Sulphonamides and their use HOFFMANN LA ROCHE (CH) 2001-09-19 — — EP disclosed
US-6030976-A SELECTIVE AFFINITY TO 5HT-6 RECEPTORS; CENTRAL NERVOUS SYSTEM DISORDERS; ALZHEIMER'S DISEASE, PSYCHOSES, SCHIZOPHRENIA, MANIC DEPRESSIONS, MEMORY DISORDERS, PARKINSON'S DISEASE, AMYOTROPHIC LATERAL SCLEROSIS AND HUNTINGTON'S DISEASE HOFFMAN-LA ROCHE INC. (US) 2000-02-29 — — US disclosed
US-5998665-A THERAPY FOR NERVOUS SYSTEM DISORDERS HOFFMANN-LA ROCHE INC. (US) 1999-12-07 — — US disclosed
US-5939451-A INDOL-4-YL-BENZENESULFONAMIDES AS ACTIVE MATERIAL TREATING MALARIA, BACTERIAL INFECTION, NEUROLOGICAL DISORDERS HOFFMANN-LA ROCHE INC. (US) 1999-08-17 — — US disclosed
US-5932599-A 4-AMINO-N-(PYRIDINYL-4-YL)-BENZENESULFONAMIDES AS ACTIVE MATERIAL TREATING MALARIA, BACTERIAL INFECTION, NEUROLOGICAL DISORDERS HOFFMANN-LA ROCHE INC. (US) 1999-08-03 — — US disclosed
EP-0815861-A1 Sulphonamides and their use F. HOFFMANN-LA ROCHE AG (CH) 1998-01-07 — — EP disclosed
Send feedback